Health Trials

Advanced Solid Tumour

4

Review clinical trials related to Advanced Solid Tumour. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)]

An open-label, multicenter, phase II clinical study to evaluate the efficacy and safety of LBL-024 in combination with other drugs for the treatment of patients with advanced solid tumour.

Participants needed: 140
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Nanjing Leads Biolabs Co.,LtdUpdated: May 26, 2026Locations: 8
Eligibility criteria

Agree to follow the trial treatment regimen, visit schedule, laboratory test, an... [+6]

Participation in clinical studies of antineoplastic agents within 4 weeks before... [+7]

Read more
Status: Recruiting

A Phase II Clinical Study of LBL-024 Combination Therapy in Patients With Advanced Solid Tumour[Substudy 03(ESCC)]

An Open-label, Multicenter, Phase II Clinical Study to Evaluate the Efficacy and Safety of LBL-024 in Combination With Other Drugs for the Treatment of Patients With Advanced Solid Tumour.

Participants needed: 110
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Nanjing Leads Biolabs Co.,LtdUpdated: May 18, 2026Locations: 7
Eligibility criteria

Agree to follow the trial treatment regimen, visit schedule, laboratory test, an... [+6]

Participation in clinical studies of antineoplastic agents within 4 weeks before... [+7]

Read more
Status: Recruiting

A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 01(NSCLC)]

An open-label, multicenter, phase II clinical study to evaluate the efficacy and safety of LBL-024 in combination with other drugs for the treatment of patients with advanced solid tumour.

Participants needed: 230
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Nanjing Leads Biolabs Co.,LtdUpdated: May 18, 2026Locations: 24
Eligibility criteria

Agree to follow the trial treatment regimen, visit schedule, laboratory test, an... [+6]

Participation in clinical studies of antineoplastic agents within 4 weeks before... [+8]

Read more
Status: Recruiting

A Phase II Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumour[Substudy 04]

An Open-label, Multicenter, Phase II Clinical Study to Evaluate the Efficacy and Safety of LBL-024 in Combination With Other Drugs for the Treatment of Patients With Advanced Solid Tumour.

Participants needed: 110
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Nanjing Leads Biolabs Co.,LtdUpdated: May 13, 2026Locations: 7
Eligibility criteria

Agree to follow the trial treatment regimen, visit schedule, laboratory test, an... [+7]

Participation in clinical studies of antineoplastic agents within 4 weeks before... [+7]

Read more